IceCure Medical Ltd
ICCM
$1.13
-$0.015-1.32%
NASDAQ
| 12/31/2023 | 12/31/2023 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Net Income | 25.13% | 25.13% | -2.85% | ||
| Total Depreciation and Amortization | 1.22% | 1.22% | 3.80% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -94.15% | -90.46% | 1,210.00% | ||
| Change in Net Operating Assets | 18.40% | 18.40% | 173.76% | ||
| Cash from Operations | 9.97% | 10.95% | 25.23% | ||
| Capital Expenditure | -5.19% | -5.19% | -6.94% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 133.15% | 132.41% | 150.38% | ||
| Cash from Investing | 135.70% | 134.95% | 157.28% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 353.33% | 353.33% | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 353.33% | 353.33% | -- | ||
| Foreign Exchange rate Adjustments | 317.14% | 317.14% | -16.67% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 743.65% | 743.65% | 131.02% | ||